| Name | 2-[4-(4-Methyl-1H-imidazol-5-yl)-1-piperidinyl]-4,5-dihydro-6H-im idazo[4,5,1-ij]quinolin-6-one |
|---|
| Description | AR-C66096 (FPL 66096) tetrasodium is a selective platelet P2YT receptor antagonist. AR-C66096 tetrasodium effectively blocks ADP-induced platelet aggregation. AR-C66096 tetrasodium can be used in the research of thromboembolism[1]. |
|---|---|
| Related Catalog | |
| Target |
pIC50: 8.36 (hPARP-1); 7.50 (mPARP-2)[1]. |
| References |
| Molecular Formula | C19H21N5O |
|---|---|
| Molecular Weight | 335.40 |
| Exact Mass | 335.17500 |
| PSA | 66.81000 |
| LogP | 3.10320 |